Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116629209> ?p ?o ?g. }
- W2116629209 endingPage "122" @default.
- W2116629209 startingPage "112" @default.
- W2116629209 abstract "ABSTRACT A detailed kinetic characterization of echinocandin inhibition was performed for mutant 1,3-β- d -glucan synthase enzymes from clinical isolates of Candida albicans with nine different FKS1 mutations resulting in high MICs. Among 14 mutant Fks1p enzymes studied, the kinetic parameters 50% inhibitory concentration and K i increased 50-fold to several thousandfold relative to those for the wild type. Enzymes with mutations at Ser645 (S645P, S645Y, and S645F) within hot spot 1 showed the most prominent decrease in sensitivity, while those with mutations at the N- and C-terminal ends of hot spot 1 generally retained greater sensitivity to all three drugs. Kinetic inhibitions by caspofungin, micafungin, and anidulafungin were comparable among the fks1 mutant enzymes, although absolute values did vary with specific mutations. Amino acid substitutions in Fks1p did not alter K m values, although some mutations decreased the V max . Given the association of FKS1 mutations with clinical resistance, an evaluation of the kinetic parameters for the inhibition of mutant 1,3-β- d -glucan synthase as a function of the MIC enabled an independent evaluation of the recently adopted susceptibility breakpoint for echinocandin drugs. Overall, a breakpoint MIC of ≥2 μg/ml for caspofungin captured nearly 100% of fks1 C. albicans strains when a kinetic inhibition rise threshold of ≤50-fold for the K i was used as a measure of susceptibility. A similar MIC breakpoint for micafungin and anidulafungin was less inclusive, and a projected MIC of ≥0.5 μg/ml was required for >95% coverage of clinical isolates. However, when MIC determinations were performed in the presence of 50% serum, all fks1 mutants showed MIC values of ≥2 μg/ml for the three echinocandin drugs. The 1,3-β- d -glucan synthase kinetic inhibition data support the proposed susceptibility breakpoint for caspofungin in C. albicans , but a lower susceptibility breakpoint (≤0.5 μg/ml) may be more appropriate for anidulafungin and micafungin. Overall, the data indicate that MIC testing with caspofungin may serve as a surrogate marker for resistance among the class of echinocandin drugs." @default.
- W2116629209 created "2016-06-24" @default.
- W2116629209 creator A5005383633 @default.
- W2116629209 creator A5016729618 @default.
- W2116629209 creator A5020852034 @default.
- W2116629209 date "2009-01-01" @default.
- W2116629209 modified "2023-10-15" @default.
- W2116629209 title "Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints" @default.
- W2116629209 cites W1481725570 @default.
- W2116629209 cites W1885778179 @default.
- W2116629209 cites W1960827163 @default.
- W2116629209 cites W1970700571 @default.
- W2116629209 cites W1976510938 @default.
- W2116629209 cites W1986481314 @default.
- W2116629209 cites W1994613828 @default.
- W2116629209 cites W1995291620 @default.
- W2116629209 cites W2005936443 @default.
- W2116629209 cites W2006277360 @default.
- W2116629209 cites W2032136872 @default.
- W2116629209 cites W2038778410 @default.
- W2116629209 cites W2042565484 @default.
- W2116629209 cites W2055556740 @default.
- W2116629209 cites W2066815221 @default.
- W2116629209 cites W2085708633 @default.
- W2116629209 cites W2093642248 @default.
- W2116629209 cites W2095786244 @default.
- W2116629209 cites W2095793596 @default.
- W2116629209 cites W2098169836 @default.
- W2116629209 cites W2100967944 @default.
- W2116629209 cites W2106925297 @default.
- W2116629209 cites W2107629327 @default.
- W2116629209 cites W2108244474 @default.
- W2116629209 cites W2108491966 @default.
- W2116629209 cites W2109890308 @default.
- W2116629209 cites W2110211897 @default.
- W2116629209 cites W2114785045 @default.
- W2116629209 cites W2116355036 @default.
- W2116629209 cites W2117461892 @default.
- W2116629209 cites W2121094454 @default.
- W2116629209 cites W2121243320 @default.
- W2116629209 cites W2122363207 @default.
- W2116629209 cites W2128243354 @default.
- W2116629209 cites W2134152343 @default.
- W2116629209 cites W2134462659 @default.
- W2116629209 cites W2137119350 @default.
- W2116629209 cites W2138910991 @default.
- W2116629209 cites W2139153322 @default.
- W2116629209 cites W2141751620 @default.
- W2116629209 cites W2143508569 @default.
- W2116629209 cites W2146555604 @default.
- W2116629209 cites W2147530964 @default.
- W2116629209 cites W2147605389 @default.
- W2116629209 cites W2147757952 @default.
- W2116629209 cites W2148641130 @default.
- W2116629209 cites W2154403663 @default.
- W2116629209 cites W2162007379 @default.
- W2116629209 cites W2163949202 @default.
- W2116629209 cites W2167190041 @default.
- W2116629209 cites W2167509781 @default.
- W2116629209 cites W2168956077 @default.
- W2116629209 cites W4254426272 @default.
- W2116629209 doi "https://doi.org/10.1128/aac.01162-08" @default.
- W2116629209 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2612148" @default.
- W2116629209 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18955538" @default.
- W2116629209 hasPublicationYear "2009" @default.
- W2116629209 type Work @default.
- W2116629209 sameAs 2116629209 @default.
- W2116629209 citedByCount "224" @default.
- W2116629209 countsByYear W21166292092012 @default.
- W2116629209 countsByYear W21166292092013 @default.
- W2116629209 countsByYear W21166292092014 @default.
- W2116629209 countsByYear W21166292092015 @default.
- W2116629209 countsByYear W21166292092016 @default.
- W2116629209 countsByYear W21166292092017 @default.
- W2116629209 countsByYear W21166292092018 @default.
- W2116629209 countsByYear W21166292092019 @default.
- W2116629209 countsByYear W21166292092020 @default.
- W2116629209 countsByYear W21166292092021 @default.
- W2116629209 countsByYear W21166292092022 @default.
- W2116629209 countsByYear W21166292092023 @default.
- W2116629209 crossrefType "journal-article" @default.
- W2116629209 hasAuthorship W2116629209A5005383633 @default.
- W2116629209 hasAuthorship W2116629209A5016729618 @default.
- W2116629209 hasAuthorship W2116629209A5020852034 @default.
- W2116629209 hasBestOaLocation W21166292091 @default.
- W2116629209 hasConcept C104317684 @default.
- W2116629209 hasConcept C138626823 @default.
- W2116629209 hasConcept C143065580 @default.
- W2116629209 hasConcept C176947019 @default.
- W2116629209 hasConcept C206936463 @default.
- W2116629209 hasConcept C2776222947 @default.
- W2116629209 hasConcept C2779020398 @default.
- W2116629209 hasConcept C2779320740 @default.
- W2116629209 hasConcept C2779548794 @default.
- W2116629209 hasConcept C2780402444 @default.
- W2116629209 hasConcept C2780651595 @default.
- W2116629209 hasConcept C2780917455 @default.
- W2116629209 hasConcept C2910751997 @default.